1. Bruniera FR, Ferreira FM, Saviolli LRM, Bacci MR, Feder D, Azzalis LA,et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19:694-700
2. Rubinstein E, Keynan Y. Vancomycin revisited – 60 years later. Frontiersin. 2014;217(2):1-7
4. Drugs.com. Vancomycin. 2019. Available from: https://www.drugs.com/ppa/vancomycin.html
8. Prescriber’s digital reference. Vancomycin- drug summary. 2018. Available from: https://www.pdr.net/drug-summary/Vancocin-vancomycin-hydrochloride-802
13. Patel S, Preuss CV, Bernice F. Vancomycin. [Updated 2019 Aug 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459263/
15. Gold Standard. Drug monograph: vancomycin. 2018. Available from: https://remote-lib.ui.ac.id:2066/#!/content/drug_monograph/6-s2.0-638?scrollTo=%23Contraindications
16. Woburn MA. Firvanq (vancomycin oral solution compounding kit) package insert. CutisPharma, Inc. 2018
17. Deerfield IL. Vancomycin pre-mixed Galaxy intravenous solution package insert. Baxter Healthcare Corporation. 2017
18. Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clinical Infectious Diseases. 2009;49(7):1072–1079
19. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel d-Ala-d-Ser gene cluster, vanL. Antimicrob Agents Chemother. 2008;52(7):2667–72
20. Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother. 2011;66(8):1831–8